Lightstone REIT V Reports Director and Officer Changes

Lightstone Value Plus Reit V, Inc. 8-K Filing Summary
FieldDetail
CompanyLightstone Value Plus Reit V, Inc.
Form Type8-K
Filed DateSep 18, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$66,000, $1,500, $750
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Lightstone REIT V filed an 8-K on 9/18/25 for director/officer changes and comp arrangements as of 9/15/25.

AI Summary

Lightstone Value Plus REIT V, Inc. filed an 8-K on September 18, 2025, reporting changes related to its board of directors and certain officers, as well as compensatory arrangements. The filing indicates a report date of September 15, 2025, for these events.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: low — This filing is routine and reports standard corporate governance changes without immediate financial implications.

Key Players & Entities

  • Lightstone Value Plus REIT V, Inc. (company) — Registrant
  • September 15, 2025 (date) — Earliest event reported
  • September 18, 2025 (date) — Filing date

FAQ

What specific changes were made to the board of directors?

The filing indicates changes related to the departure and election of directors, but specific names are not detailed in the provided excerpt.

Were there any changes in the company's officers?

Yes, the filing reports changes concerning certain officers of Lightstone Value Plus REIT V, Inc.

What is the exact date of the events reported in the 8-K?

The earliest event reported is dated September 15, 2025.

When was this 8-K filing submitted to the SEC?

The filing was submitted on September 18, 2025.

What other items are covered in this 8-K filing besides director and officer changes?

The filing also covers compensatory arrangements of certain officers.

Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-09-18 15:44:33

Key Financial Figures

  • $66,000 — iner fee for membership on the Board of $66,000, which is paid in four equal installmen
  • $1,500 — four equal installments each year, (ii) $1,500 for each board of directors or permanen
  • $750 — t committee meeting attended, and (iii) $750 for each written consent considered by

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2025 LIGHTSTONE VALUE PLUS REIT V, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 000-53650 20-8198863 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 1985 Cedar Bridge Avenue , Suite 1 Lakewood , New Jersey 08701 (Address of principal executive offices) (Zip Code) ( 732 ) 367-0129 (Registrant's telephone number, including area code) None (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) On September 15, 2025, the board of directors (the "Board") of Lightstone Value Plus REIT V, Inc. (the "Company") unanimously appointed Bruce J. Schanzer to the Board, to fill the vacancy created by the resignation of Jeffrey F. Joseph in December 2024. Mr. Schanzer was also appointed to the Audit, Conflicts, and Nominating Committees of the Board effective immediately. The Board has affirmatively determined that Mr. Schanzer is an "independent director" as defined in the Company's charter (an "Independent Director") and "independent" under the rules of the NYSE. Independent Directors, including Mr. Schanzer, currently receive (i) an annual retainer fee for membership on the Board of $66,000, which is paid in four equal installments each year, (ii) $1,500 for each board of directors or permanent committee meeting attended, and (iii) $750 for each written consent considered by the Independent Director. There are no arrangements or understandings between Mr. Schanzer and any other person pursuant to which he was appointed as a director. There are no transactions in which Mr. Schanzer has an interest that require disclosure under Item 404(a) of Regulation S-K. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIGHTSTONE VALUE PLUS REIT V, INC. Dated: September 18, 2025 By: /s/ Seth Molod Seth Molod Chief Financial Officer & Executive Vice President 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.